Articles

About Author:
Vivek P. Chavda
Department of Pharmaceutics, B.K. Mody Government Pharmacy College,
Rajkot – 360003, Gujarat (India)
vivek7chavda@gmail.com

Abstract
This technology has just revolutionized the cancer treatment. It is clearly a tool of exceptional value in the functionalization of genes and their validation as potential targets for cancer chemotherapy. Furthermore, a rapidly expanding repertoire of antisense therapy based on the use of antisense oligonucleotides (AONs), small interfering RNAs (siRNAs), micro RNAs (miRNAs), ribozymes and other antisense compounds is being developed to block over expression of key oncogenes and other tumor promoting genes in the treatment of different tumors and many of these nucleic acid-based drugs have demonstrated impressive preclinical and clinical responses.This review highlight some of the cardinal feature of this technology.

The constantly increasing sales volume of baby toiletries in the overall cosmetic market indicates their relative importance to the consumer, manufacturer, retailer and pediatrician. These products include:

About Authors:
Yashodhara Choubey*, Mr. Govind Bhandari, Mr. Avnish Sharma, Mr. Mukesh Mehra
Mahakal Institute of Pharmaceutical Studies,
Ujjain (M.P.), India
*yashodhara.juhipharma@gmail.com

About Authors:
M. B. Shinde*, S.V.Usnale¹, M. B. Sorde², O.V. Kolgire³
Department of quality assurance,
Maharashtra College Of Pharmacy, Nilanga.
Dist- latur (MS)
*maheshinde7@gmail.com

ABOUT AUTHORS:
Mr. Diptesh A. Patel¹*, Mrs. Pinkal H. Patel¹, Mr. Rohit K. Patel^2
1Department of Quality Assurance, Baroda college of pharmacy, Vadodara, Gujarat, India.
²Department of Quality Assurance, Kaptab Pharmaceutical, Vadodara, Gujarat, India.
*dipteshpatel88@yahoo.com

ABOUT AUTHORS:
Girish Kumar Tripatha*, Satyawan Singha
Bio-organic chemistry Laboratory,
Saroj Institute of Technology & Management Lucknow, India
*orgpharm@gmail.com

About Authors:
Waghmare P.V.*, Chinchole A.S.¹, Chavan D.V.², Dr.Bhusnure O.G.³
Master of pharmacy, Department of Quality Assurance (*,^{1, 2,3})
Maharashtra College of Pharmacy, Nilanga, Dist. Latur (MS) 413521, India
*pradeep.waghmare90@gmail.com

ABOUT AUTHORS:
Saurabh Kumar Singh*, Aruna Chandra Singh
Department of pharmaceutical Chemistry, Rajiv Academy for pharmacy, Mathura,
N.H. #2 Delhi-Mathura Bye-pass, P.O. Chhatikara,
Mathura-281001.Uttar Pradesh, India
*s_s_khirwar@yahoo.co.in

ABSTRACT
The rate of cancer rise is dramatic, doubling in the last 30 years. Furthermore, of the estimated 560,000 cancer victims who would die in 1997, most of them could have prevented their illness had they paid attention to some simple lifestyle factors.

Although the number of cancer deaths continues to rise each year in the U.S., the per capita cancer mortality rate has just recently started to decline. This celebrated small decline was first announced by the National Cancer Institute in late 1996, but a careful retrospective review of the data indicated that the per capita cancer death rate peaked in 1991 and has ever so slowly declined thereafter. What was the reason for this decline? Not improved cancer treatments, but cancer prevention itself emerges as the cause for this good news. A national commitment to the prevention of cancer, largely replacing reliance on hopes for universal cures.